Magazzini, Lorenzo ORCID: https://orcid.org/0000-0002-8934-8374, Muthukumaraswamy, Suresh D., Campbell, Anne E., Khalid, Hamandi, Lingford-Hughes, Anne, Myers, Jim F. M., Nutt, David J., Sumner, Petroc ORCID: https://orcid.org/0000-0002-0536-0510, Wilson, Sue J. and Singh, Krish D. ORCID: https://orcid.org/0000-0002-3094-2475 2016. Significant reductions in human visual gamma frequency by the GABA reuptake inhibitor tiagabine revealed by robust peak frequency estimation. Human Brain Mapping 37 (11) , pp. 3882-3896. 10.1002/hbm.23283 |
Preview |
PDF
- Published Version
Available under License Creative Commons Attribution. Download (864kB) | Preview |
Abstract
The frequency of visual gamma oscillations is determined by both the neuronal excitation–inhibition balance and the time constants of GABAergic processes. The gamma peak frequency has been linked to sensory processing, cognitive function, cortical structure, and may have a genetic contribution. To disentangle the intricate relationship among these factors, accurate and reliable estimates of peak frequency are required. Here, a bootstrapping approach that provides estimates of peak frequency reliability, thereby increasing the robustness of the inferences made on this parameter was developed. The method using both simulated data and real data from two previous pharmacological MEG studies of visual gamma with alcohol and tiagabine was validated. In particular, the study by Muthukumaraswamy et al. [2013a] (Neuropsychopharmacology 38(6):1105–1112), in which GABAergic enhancement by tiagabine had previously demonstrated a null effect on visual gamma oscillations, contrasting with strong evidence from both animal models and very recent human studies was re-evaluated. After improved peak frequency estimation and additional exclusion of unreliably measured data, it was found that the GABA reuptake inhibitor tiagabine did produce, as predicted, a marked decrease in visual gamma oscillation frequency. This result demonstrates the potential impact of objective approaches to data quality control, and provides additional translational evidence for the mechanisms of GABAergic transmission generating gamma oscillations in humans.
Item Type: | Article |
---|---|
Date Type: | Publication |
Status: | Published |
Schools: | Psychology Cardiff University Brain Research Imaging Centre (CUBRIC) |
Subjects: | R Medicine > RC Internal medicine > RC0321 Neuroscience. Biological psychiatry. Neuropsychiatry |
Additional Information: | This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
Publisher: | Wiley |
ISSN: | 1065-9471 |
Date of First Compliant Deposit: | 14 June 2016 |
Date of Acceptance: | 27 May 2016 |
Last Modified: | 22 May 2023 00:21 |
URI: | https://orca.cardiff.ac.uk/id/eprint/91801 |
Citation Data
Cited 23 times in Scopus. View in Scopus. Powered By Scopus® Data
Actions (repository staff only)
Edit Item |